Nurix Therapeutics, Inc. (NRIX)
26.71
-0.24
(-0.89%)
USD |
NASDAQ |
Aug 26, 16:00
26.70
0.00 (0.00%)
After-Hours: 20:00
Nurix Therapeutics Total Return Level : 26.71 for Aug. 26, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 26, 2026 | 26.71 |
| August 25, 2026 | 26.95 |
| August 24, 2026 | 26.27 |
| August 21, 2026 | 26.72 |
| August 20, 2026 | 27.05 |
| August 19, 2026 | 27.79 |
| August 18, 2026 | 26.93 |
| August 17, 2026 | 27.17 |
| August 14, 2026 | 27.05 |
| August 13, 2026 | 27.19 |
| August 12, 2026 | 26.63 |
| August 11, 2026 | 25.96 |
| August 10, 2026 | 25.88 |
| August 07, 2026 | 25.53 |
| August 06, 2026 | 25.22 |
| August 05, 2026 | 25.12 |
| August 04, 2026 | 24.69 |
| August 03, 2026 | 23.22 |
| July 31, 2026 | 23.21 |
| July 30, 2026 | 23.58 |
| July 29, 2026 | 23.60 |
| July 28, 2026 | 24.15 |
| July 27, 2026 | 23.43 |
| July 24, 2026 | 23.38 |
| July 23, 2026 | 23.74 |
| Date | Value |
|---|---|
| July 22, 2026 | 23.60 |
| July 21, 2026 | 23.48 |
| July 20, 2026 | 22.71 |
| July 17, 2026 | 23.12 |
| July 16, 2026 | 23.07 |
| July 15, 2026 | 23.85 |
| July 14, 2026 | 22.98 |
| July 13, 2026 | 22.71 |
| July 10, 2026 | 23.06 |
| July 09, 2026 | 24.69 |
| July 08, 2026 | 24.31 |
| July 07, 2026 | 24.40 |
| July 06, 2026 | 24.04 |
| July 02, 2026 | 23.97 |
| July 01, 2026 | 23.91 |
| June 30, 2026 | 24.26 |
| June 29, 2026 | 23.85 |
| June 26, 2026 | 22.90 |
| June 25, 2026 | 22.46 |
| June 24, 2026 | 19.30 |
| June 23, 2026 | 18.86 |
| June 22, 2026 | 18.65 |
| June 18, 2026 | 17.55 |
| June 17, 2026 | 17.12 |
| June 16, 2026 | 17.07 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Monte Rosa Therapeutics, Inc. | 14.38 |
| Gilead Sciences, Inc. | 215.83 |
| TG Therapeutics, Inc. | 55.03 |
| Cue Biopharma, Inc. | 28.85 |
| Keros Therapeutics, Inc. | 11.12 |